GSK360A orally active HIF-PHD inhibitor. GSK360A exerts systemic and local effects by stabilizing HIF-1alpha signaling and improves long-term ventricular function, remodeling, and vascularity in a model of established ventricular dysfunction. These findings suggest that GSK360A may be suitable for the treatment of post-MI remodeling and heart failure. Form: Beige Solid Melting Point: 195-197C Solubility: Methanol
Molecular Weight:
348.33
Form:
Beige Solid
CAS Number:
[931399-19-8]
* VAT and and shipping costs not included. Errors and price changes excepted